scispace - formally typeset
E

Erwin W. Gelfand

Researcher at University of Colorado Denver

Publications -  679
Citations -  37565

Erwin W. Gelfand is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Immunoglobulin E & T cell. The author has an hindex of 99, co-authored 675 publications receiving 36059 citations. Previous affiliations of Erwin W. Gelfand include University of Colorado Hospital & University of Virginia.

Papers
More filters
Journal Article

Functional thrombin receptors on human T lymphoblastoid cells.

TL;DR: Findings demonstrate functional thrombin receptors on T lymphoblastoid cells that may be capable of activating the cells, independently of an ongoing immune response.
Journal ArticleDOI

Mesenchymal Stem Cells Recruit CCR2+ Monocytes To Suppress Allergic Airway Inflammation.

TL;DR: It is suggested that MSC activation by IFN-γ, followed by increased expression of CCL2 and recruitment of monocytes to the lungs, is essential for suppression by MSC in allergen-induced airway hyperresponsiveness and airway inflammation.
Journal ArticleDOI

The E-rosette assay: a cautionary note.

TL;DR: Study of both patients and treated lymphocyte preparations indicated that the use of untreated SRBC in the E-rosette assay failed to detect certain T-cell subpopulations whereas assays using treated SRBC were insensitive to differences in the binding properties of distinct T- cell subsets.
Journal ArticleDOI

Montelukast during Primary Infection Prevents Airway Hyperresponsiveness and Inflammation after Reinfection with Respiratory Syncytial Virus

TL;DR: In this paper, the effects of montelukast (MK), a cysteinyl leukotriene (cysLT) receptor antagonist, in primary and secondary RSV-infected newborn and adult mice were evaluated.